3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Diabetes - Drug News - Obesity -

Diabetes, Cholesterol, Anti-obesity Drugs Top Spending

Diabetes • • Drug News • • ObesityFeb 14, 08

U.S. adult consumers spent nearly $36 billion for prescription drugs to lower blood sugar, reduce cholesterol, or help with other metabolic problems in 2005, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

The four other classes of drugs that topped spending among adults were:
• Cardiovascular drugs, for reducing high blood pressure and treating heart conditions ($33 billion).
• Central nervous system drugs, which include pain killers; sleep aid medications and medications for attention deficit disorder ($26 billion).
• Antidepressants and antipsychotic drugs ($17 billion).
• Gastrointestinal drugs including antacids and laxatives ($15 billion).

Purchases of these five top classes of drugs totaled $127 billion in 2005 – nearly two thirds of the total $199 billion spent on all outpatient prescription medicines.

AHRQ, which is part of the U.S. Department of Health and Human Services, works to enhance the quality, safety, efficiency, and effectiveness of health care in the United States. The data in this AHRQ News and Numbers summary are taken from the Medical Expenditure Panel Survey, a detailed source of information on the health services used by Americans, the frequency with which they are used, the cost of those services, and how they are paid. For more information, go to The Top Therapeutic Classes of Outpatient Prescription Drugs Ranked by Total Expense for Adults Age 18 and Older in the U.S. Civilian Noninstitutionalized Population, 2005

Source: Agency for Healthcare Research and Quality (AHRQ)



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  UGA ecologist finds another cause of antibiotic resistance
  Implantable ‘artificial pancreas’ could help diabetes patients control their blood sugar
  New drug for neuroblastoma shows promise in phase I study
  Baclofen shows promise in patients with alcohol-induced liver disease
  Quitting smoking has favorable metabolic effects
  Joslin researchers find drugs are effective for diabetic macular edema in new trial
  Findings point to an ‘off switch’ for drug resistance in cancer
  New superfoods could help key protein keep bodies healthy
  Poor quality of life may affect teens’ diabetes management
  Stopping statins may benefit terminally ill patients
  Cholesterol drug users may use pills as a license to overeat

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site